Formulation development

Automated and high-throughput systems accelerate time to final drug product

Our deep understanding of the nature of large molecules derived from our drug substance development activities serves as the basis to efficiently develop a formulation. This synergistic approach enables us to provide targeted and rapid drug product development.

Drug product formulation

Whilst applying a broad array of high-throughput technologies, we provide rapid formulation development accompanied by simultaneous real-time and accelerated stability testing according to ICH standards.

We use a semiautomatic filling machine to determine critical process parameters and to produce aseptic drug product for preclinical studies.

Automated and high-throughput formulation development:

We provide rapid and highly automated formulation development to our partners, utilizing:

  • UNit 445 for rapid excipient screening
  • Freeslate Protegé 300 for automated visible particles, colour and turbidity measurements
  • Semi-automated filling and crimping station
  • DSC for melting temperatures determination

Working with our Drug Product Team

“We are committed to positive outcomes and delivering projects on time to specification”

We can support any projects formulation development and utlize our know-how, state-of-the-art equipment and technologies to deliver a formulation optimized for your therapeutic.

Contact us

Related material

Please read and watch our range of materials produced by our scientists. Including articles, scientific papers, webinars, brochures and videos.

Let’s collaborate and create quality biologics together.

Get in touch for more information.

We use cookies

Polpharma Biologics uses cookies and other similar technologies (hereinafter: cookies) on its webpages and mobile applications (hereinafter, jointly, Website). The user can manage cookies independently by changing the web browser settings. If you do not consent for your personal data to be collected via cookies, you should change your web browser settings or stop using the Website.

Using the Website without changing the web browser settings indicates your acceptance of the use of cookies by Polpharma. Acceptance of the web browser settings indicates your consent to profiling on the basis of the information contained in cookies. Consent may be withdrawn at any time. Withdrawal of consent does not affect lawfulness of any processing activities carried out under consent before its withdrawal.

For more details see the Cookie Policy.